Featured Image
Perspectives
This publication demonstrates the implications of the European Falsified Medicines Directive on secondary care and provides insight into the obstacles faced by healthcare professionals in protecting patients against the threat of conterfeit medicines in the legal supply chain.
Mr Bernard D Naughton
Keele University
Read the Original
This page is a summary of: EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review, Journal of Generic Medicines The Business Journal for the Generic Medicines Sector, September 2015, SAGE Publications,
DOI: 10.1177/1741134316643358.
You can read the full text:
Contributors
The following have contributed to this page
